Hyperparathyroidism-jaw tumor syndrome confirmed by preoperative genetic testing

8Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

We herein report the case of a young woman who was diagnosed with primary hyperparathyroidism and in whom genetic testing confirmed a diagnosis of hyperparathyroidism-jaw tumor syndrome. Familial hyperparathyroidism was suspected based on the patient’s young age at the onset of the disease. Thus, genetic testing was performed. It showed a germline mutation in the HRPT2/CDC73 gene and confirmed the diagnosis of hyperparathyroidism-jaw tumor syndrome. Total parathyroidectomy was performed to prevent recurrence. In patients with early-onset hyperparathyroidism, genetic testing should be considered to facilitate the selection of a proper surgical procedure based on the consideration of future life expectancy.

Cite

CITATION STYLE

APA

Koikawa, K., Okada, Y., Mori, H., Kawaguchi, M., Uchino, S., & Tanaka, Y. (2018). Hyperparathyroidism-jaw tumor syndrome confirmed by preoperative genetic testing. Internal Medicine, 57(6), 841–844. https://doi.org/10.2169/internalmedicine.9509-17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free